Aclaris Therapeutics (ACRS) Change in Accured Expenses (2014 - 2026)
Aclaris Therapeutics' quarterly Change in Accured Expenses came in at -$3.0 million in Q1 2026, up 72.6% year-on-year from -$1.8 million in Q1 2025, and down 341.89% quarter-over-quarter from $1.3 million in Q4 2025.
Aclaris Therapeutics has reported Change in Accured Expenses for 13 years, with the latest figure at -$3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 72.6% year-over-year to -$3.0 million; the trailing twelve-month figure through Mar 2026 stood at -$81000.0 (up 96.1% YoY), and the FY2025 full-year result was -$8.1 million, down 105.4% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$3.0 million, down from $1.3 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $11.6 million in Q4 2024, with the low at -$12.9 million in Q1 2024.
- Average Change in Accured Expenses over 5 years is -$146000.0, with a median of $399000.0 recorded in 2025.
- Year-over-year, Change in Accured Expenses jumped 928.49% in 2023 and slumped 1012.67% in 2024.
- Tracing ACRS's Change in Accured Expenses over 5 years: stood at -$681000.0 in 2022, then jumped by 928.49% to $5.6 million in 2023, then jumped by 105.1% to $11.6 million in 2024, then slumped by 89.19% to $1.3 million in 2025, then slumped by 341.89% to -$3.0 million in 2026.
- The last three Change in Accured Expenses figures came in at -$3.0 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Aclaris Therapeutics | 586.09 Mn | 586.09 Mn | 1.60 Mn | -3.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.03 Mn |
| Mar 31, 2026 | -3.03 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 399,000.00 |
| Jun 30, 2025 | 399,000.00 |
| Mar 31, 2025 | -11.04 Mn |
| Mar 31, 2025 | -11.04 Mn |
| Dec 31, 2024 | 11.57 Mn |
| Dec 31, 2024 | 11.57 Mn |
| Sep 30, 2024 | -1.15 Mn |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -1.46 Mn |
| Jun 30, 2024 | -1.46 Mn |
| Mar 31, 2024 | -12.91 Mn |
| Mar 31, 2024 | -12.91 Mn |
| Dec 31, 2023 | 5.64 Mn |
| Dec 31, 2023 | 5.64 Mn |
| Sep 30, 2023 | 6.59 Mn |
| Sep 30, 2023 | 6.59 Mn |
| Jun 30, 2023 | 916,000.00 |
| Jun 30, 2023 | 916,000.00 |
| Mar 31, 2023 | -1.16 Mn |
| Mar 31, 2023 | -1.16 Mn |
| Dec 31, 2022 | -681,000.00 |
| Dec 31, 2022 | -681,000.00 |
| Sep 30, 2022 | 1.45 Mn |
| Sep 30, 2022 | 1.45 Mn |
| Jun 30, 2022 | 1.67 Mn |
| Jun 30, 2022 | 1.67 Mn |
| Mar 31, 2022 | -1.85 Mn |
| Mar 31, 2022 | -1.85 Mn |
| Dec 31, 2021 | 2.54 Mn |
| Dec 31, 2021 | 2.54 Mn |
| Sep 30, 2021 | -2.93 Mn |
| Sep 30, 2021 | -2.93 Mn |
| Jun 30, 2021 | 3.29 Mn |
| Jun 30, 2021 | 3.29 Mn |
| Mar 31, 2021 | -2.43 Mn |
| Mar 31, 2021 | -2.43 Mn |
| Dec 31, 2020 | 1.71 Mn |
| Dec 31, 2020 | 1.71 Mn |
| Sep 30, 2020 | -5.53 Mn |
| Sep 30, 2020 | -5.53 Mn |
| Jun 30, 2020 | -2.14 Mn |
| Jun 30, 2020 | -2.14 Mn |
| Mar 31, 2020 | 2.23 Mn |
| Mar 31, 2020 | 2.23 Mn |
| Dec 31, 2019 | -8.78 Mn |
| Dec 31, 2019 | -8.78 Mn |
| Sep 30, 2019 | -7.07 Mn |
| Sep 30, 2019 | -7.07 Mn |
| Jun 30, 2019 | 5.36 Mn |
| Jun 30, 2019 | 5.36 Mn |
| Mar 31, 2019 | 8.52 Mn |
| Mar 31, 2019 | 8.52 Mn |
| Dec 31, 2018 | 3.93 Mn |
| Dec 31, 2018 | 3.93 Mn |
| Sep 30, 2018 | 1.23 Mn |
| Sep 30, 2018 | 1.23 Mn |
| Jun 30, 2018 | 848,000.00 |
| Jun 30, 2018 | 848,000.00 |
| Mar 31, 2018 | 788,000.00 |
| Mar 31, 2018 | 788,000.00 |
| Dec 31, 2017 | 621,000.00 |
| Dec 31, 2017 | 621,000.00 |
| Sep 30, 2017 | 1.15 Mn |
| Sep 30, 2017 | 1.15 Mn |
| Jun 30, 2017 | 369,000.00 |
| Jun 30, 2017 | 369,000.00 |
| Mar 31, 2017 | -1.54 Mn |
| Mar 31, 2017 | -1.54 Mn |
| Dec 31, 2016 | 460,000.00 |
| Dec 31, 2016 | 460,000.00 |
| Sep 30, 2016 | 637,000.00 |
| Sep 30, 2016 | 637,000.00 |
| Jun 30, 2016 | 1.31 Mn |
| Jun 30, 2016 | 1.31 Mn |
| Mar 31, 2016 | 39,000.00 |
| Mar 31, 2016 | 39,000.00 |
| Dec 31, 2015 | -20,000.00 |
| Dec 31, 2015 | -20,000.00 |
| Sep 30, 2015 | 294,000.00 |
| Sep 30, 2015 | 294,000.00 |
| Jun 30, 2015 | 262,000.00 |
| Jun 30, 2015 | 262,000.00 |
| Mar 31, 2015 | 16,000.00 |
| Mar 31, 2015 | 16,000.00 |
| Dec 31, 2014 | -330,000.00 |
| Dec 31, 2014 | -330,000.00 |